The European Psychiatric Association (EPA) was founded in 1983. With active individual members in as many as 88 countries and 43 National Psychiatric Association Members who represent over 80,000 European psychiatrists, the EPA is the main association representing psychiatry in Europe. Its mission is to improve psychiatry and mental health care in Europe. EPA members include leading experts in numerous fields. The EPA's activities address the interests of psychiatrists in academia, research and practice throughout all stages of career development. Together, EPA members contribute to the life of the association and to the development of psychiatry in Europe. Each member has the possibility to actively contribute to ongoing projects and play a key role in shaping the future of the association and its policies. The EPA 2019 scientific programme is composed of five tracks.
The scientific session is the world premier diabetes meeting, bringing together over 14000 Participants including more than 11000 physicians, clinicians, nurses, dietitians, CDE A and researchers, Join over 145 companies representing 700 booths.